NCT01086423
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +23 more
- Locations
-
- GSK Investigational Site Wuzhou, Guangxi, China
- GSK Investigational Site Wuzhou, Guangxi, China
Clinical trial condition
Picornaviridae Infections
Explore clinical trials studying Picornaviridae Infections. Study availability and eligibility vary by location and protocol.
557 public trials
30 recruiting studies
Picornaviridae Infections trial results
NCT00627458
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +32 more
- Locations
-
- GSK Investigational Site Jarvenpaa, Finland
- GSK Investigational Site Oulu, Finland
- GSK Investigational Site Pori, Finland
- GSK Investigational Site Tampere, Finland
NCT00635128
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +24 more
- Locations
-
- GSK Investigational Site Ettenheim, Baden-Wurttemberg, Germany
- GSK Investigational Site Kehl, Baden-Wurttemberg, Germany
- GSK Investigational Site Oberkirch, Baden-Wurttemberg, Germany
- GSK Investigational Site Offenburg, Baden-Wurttemberg, Germany
Completed
Immunogenicity and Safety of Booster Dose of BoostrixTM Polio Vaccine in Previously Boosted Adults
NCT01323959
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +19 more
- Locations
-
- GSK Investigational Site Derval, France
- GSK Investigational Site La Chapelle-Basse-Mer, France
- GSK Investigational Site La Riche, France
- GSK Investigational Site Nantes, France
Completed
Immunogenicity and Safety of Boostrix Polio Vaccine as a Booster Dose in 5 to 6-year-old Children.
NCT00871000
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +19 more
- Locations
-
- GSK Investigational Site Genoa, Liguria, Italy
- GSK Investigational Site Milan, Lombardy, Italy
- GSK Investigational Site Novara, Piedmont, Italy
- GSK Investigational Site Cagliari, Sardinia, Italy
NCT00325143
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +23 more
- Locations
-
- GSK Investigational Site Singapore
- GSK Investigational Site Singapore
- GSK Investigational Site Singapore
NCT00964028
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +23 more
- Locations
-
- GSK Investigational Site Wuzhou, Guangxi, China
Completed
A Phase 2 Study of Vapendavir in Asthmatic Adults With Symptomatic Human Rhinovirus Infection
NCT02367313
- Conditions
- Asthma, Bronchial Diseases, Common Cold, +12 more
- Locations
-
- Biota Investigational site Birmingham, Alabama, United States
- Biota Investigational site Flagstaff, Arizona, United States
- Biota Investigational site Bakersfield, California, United States
- Biota Investigational site Los Angeles, California, United States
NCT01086709
- Conditions
- Blood-Borne Infections, Cervical Neoplasia, Communicable Diseases, +23 more
- Locations
-
- Proyecto Epidemiologico Guanaste (PEG) San José, Costa Rica
NCT02815878
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Central Nervous System Diseases, +30 more
- Locations
-
- University of Washington Seattle, Washington, United States